The Role of COX-2 Expression in Locally Advanced Rectal Cancer Treated with Neoadjuvant Concurrent Radiation with Capecitabine/Oxaliplatin and Celecoxib

被引：0
|
作者：
Cai, G. [1 ]
Zhang, Z. [1 ]
Zhu, J. [1 ]
Gu, W. [1 ]
Zhang, S. [1 ]
Hu, Y. [1 ]
Li, G. [1 ]
Cai, S. [1 ]
机构：
[1] Fudan Univ, Canc Hosp, Shanghai 200433, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2009.07.602
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S261 / S261
页数：1
相关论文
共 50 条
  • [1] PHASE II STUDY OF NEOADJUVANT CONCURRENT RADIATION WITH CAPECITABINE/OXALIPLATIN AND CELECOXIB IN UNRESECTABLE LOCALLY ADVANCED RECTAL CANCER
    Cai, G.
    Zhang, Z.
    Zhu, J.
    Gu, W.
    Hu, Y.
    Li, G.
    Cai, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 142 - 142
  • [2] Neoadjuvant Capecitabine and Oxaliplatin Before Concurrent Capecitabine and Radiation in Locally Advanced Rectal Cancers: Experience of a Cancer Hospital in Pakistan
    Mansha, Muhammad Atif
    Waheed, Asmara
    Sadaf, Tabinda
    Rashid, Asma
    Irfan, Nabia
    Chaudry, Samreen Javed
    JCO GLOBAL ONCOLOGY, 2021, 7 : 790 - 796
  • [3] CEX (celecoxib, oxaliplatin, capecitabine) and XRT: A novel neoadjuvant approach for locally advanced rectal cancer
    Adler, WM
    Liem, B
    Heywood, G
    Wong, G
    Lee, FC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 306S - 306S
  • [4] Neoadjuvant capecitabine and oxaliplatin (XELOX) with bevacizumab for locally advanced rectal cancer
    Hasegawa, Junichi
    Mizushima, Tsunekazu
    Kim, Ho Min
    Miyake, Yasuhiro
    Takemoto, Hiroyoshi
    Tamagawa, Hiroshi
    Noura, Shingo
    Ohue, Masayuki
    Fujii, Makoto
    Fujie, Yuichiro
    Ota, Hirofumi
    Kato, Takeshi
    Fukunaga, Mutsumi
    Takemasa, Ichiro
    Ikeda, Masataka
    Yamamoto, Hirofumi
    Sekimoto, Mistugu
    Nezu, Riichiro
    Doki, Yuichiro
    Mori, Masaki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] Role of Oxaliplatin in the Neoadjuvant Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: a Review of Evidence
    Nazari, Reza
    Piozzi, Guglielmo Niccolo
    Ghalehtaki, Reza
    Ahmadi-Tafti, Seyed Mohsen
    Behboudi, Behnam
    Darzikolaee, Nima Mousavi
    Aghili, Mahdi
    Gambacorta, Maria Antonietta
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2024, 18
  • [6] Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer
    Hanan Ahmed Wahba
    Hend Ahmed El-Hadaad
    Ehab Atef Abd-Ellatif
    Medical Oncology, 2012, 29 : 1693 - 1698
  • [7] Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer
    Wahba, Hanan Ahmed
    El-Hadaad, Hend Ahmed
    Abd-Ellatif, Ehab Atef
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1693 - 1698
  • [8] NEOADJUVANT IRRADIATION IN LOCALLY ADVANCED RECTAL CANCER WITH SIMULTANEOUS ADMINISTRATION OF CAPECITABINE AND OXALIPLATIN
    Winkler, J.
    Zipp, L.
    Knoblich, J.
    Zimmermann, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (12) : 741 - 741
  • [9] RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer
    Wong, S. J.
    Winter, K.
    Meropol, N. J.
    Anne, R.
    Kachnic, L. A.
    Rashid, A.
    Watson, J. C.
    Mitchell, E. P.
    Pollock, J.
    Lee, R. J.
    Willett, C. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] A Phase I Study of Capecitabine, Irinotecan, Celecoxib, and Radiation as Neoadjuvant Therapy of Patients With Locally Advanced Rectal Cancer
    Malik, Imtiaz
    Hussein, Farabi
    Bush, David
    Alqaisi, Munther
    Bernal, Pedro
    Byrd, Janet
    Garberoglio, Carlos
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 242 - 245
12345